PharmaTimes World News:
Roche has unveiled promising late-stage data on Actemra, which shows that the drug significantly improved symptoms of systemic onset juvenile idiopathic arthritis. (Read More)
PharmaTimes World News:
AstraZeneca has presented data at the American Heart Association meeting in Orlando which shows that its blockbuster cholesterol drug reduced risk of cardiovascular events in women by nearly half (46%). (Read More)
Pharmaceutical Executive Magazine:
Dubbed as the 'female Viagra,' Boehringer Ingelheim's filbanserin represents an unprecedented step
forward in treating female sexual dysfunction. (Read More)
Pharmaceutical Executive Magazine:
The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot
more than just time and money. But is pharma really capable of getting lean?. (Read More)
PharmaTimes World News:
US drugmakers say the introduction of a Food and Drug Administration internet logo would assure consumers that drug information provided on-line has been approved by the agency. (Read More)
PharmaTimes World News:
A new study is claiming that Pfizer moved the goalposts and issued misleading data when it came to analyses of off-label use of its epilepsy drug Neurontin. (Read More)
PharmaTimes World News:
Switzerland-based Nycomed has posted a 0.9% rise (or 3.2% in local currencies) in turnover for the third quarter to 820.0 million euros, a good result given the effects of generic competition to its GI drug pantoprazole. (Read More)
Main PRNN:
This month marks the 10 year anniversary of the founding of GenericsWeb as a supplier of premium patent information products and services to the Generic Pharmaceutical Industry.GenericsWeb has evolved from humble beginnings i (Read More)
Telecommunications PRNN:
Cell Based Assays for Drug Discovery http://www.bharatbook.com/MarketResearchReports/CellBasedAssaysforDrugDiscovery.html The term drug discovery tools usually refers to highcontent screening HCS and analysis and is composed (Read More)
Main PRNN:
Arrowhead8217s 2010 Allosteric and Orthosteric Modulator Congress scheduled to take place in Philadelphia PA on January 25 and January 26 2010 will highlight key developments in the field of allosteric and orthosteric modulat (Read More)
Main PRNN:
This niche drug side effects information website http://www.drugsideeffectsandclinicaltrials.com/prweb has just been awarded the prestigious HONCode certification placing it on the map alongside other reputable medical info (Read More)
Main PRNN:
PharmacyChecker.com the leading online pharmacy verification company and authority on international pharmacies expressed support today for concepts within the Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 i (Read More)
PharmaTimes World News:
GlaxoSmithKline says that it is received the thumbs-up from the World Health Organisation for Synflorix, the first endorsement for a vaccine against pneumococcal disease. (Read More)
PharmaTimes World News:
Biota Holdings of Australia and partner Daiichi Sankyo have begun a late-stage trial in Japan for the preventative use of their investigational antiviral laninamivir for influenza. (Read More)
PharmaTimes World News:
GlaxoSmithKline and partner Valeant Pharmaceuticals International have filed their investigational epilepsy treatment retigabine. (Read More)
PharmaTimes World News:
Human Genome Sciences and GlaxoSmithKline have presented more promising data on Benlysta late-stage data which the companies hope will be the first treatment to receive approval for lupus in over 50 years. (Read More)
PharmaTimes World News:
Shares in Spain’s Zeltia are on the rise this morning after regulators in Europe approved the firm’s oncology drug Yondelis for ovarian cancer. (Read More)